Search

everythinglearnresearchcommunity

for

Search:↓

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Low levels of vitamin D and ferritin may increase the risk of female pattern hair loss.

The 7.1% withdrawal rate was in the oral finasteride group, not the topical one.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Hair loss linked to prostate enlargement; stress and family history important factors.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Baldness may indicate higher heart disease risk in men.

Phototrichogram helps assess hair loss severity.

Auto-portraits help evaluate scalp hair.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

Alopecia linked to higher anxiety and personality disorders.

Hormonal differences affect male pattern baldness.

New treatment improves male hair loss.

Topical spironolactone effectively treats hair loss in women.

New therapy helps treat hair loss.

New therapy helps treat hair loss.

Liposomes improve drug delivery and reduce skin irritation in dermatology.